Biological potential and mechanisms of Brain-Expressed X-linked family proteins in cancers: an updated review

Pingping Wang1, Ziyan Chen2, Hongyan Zhang3

  • 1School of Pharmaceutical Sciences, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310053, China; Zhejiang Cancer Hospital, Hangzhou, 310022, China.

PubMed
Abstract

Insights

Brain-Expressed X-linked (BEX) proteins are emerging therapeutic targets. This review highlights their roles in inhibiting cancer cell proliferation and metastasis, offering insights for new cancer treatments.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The Brain-Expressed X-linked (BEX) protein family, comprising BEX1-5, is relatively understudied in human health and disease.
  • These proteins exhibit diverse localization, expression, and degradation patterns, influencing pathways like p75NTR involved in neuronal processes.
  • Emerging evidence links BEX proteins to various diseases, including cancers, liver, and heart conditions, suggesting therapeutic potential.

Purpose of the Study:

  • To systematically review the role of BEX family proteins in human cancers.
  • To provide insights into novel therapeutic strategies for cancer treatment.
  • To highlight the mechanisms and clinical applications of BEX proteins in oncology.

Main Methods:

  • Systematic literature review.
  • Analysis of existing research on BEX protein functions in cancer.
  • Synthesis of data on molecular signaling pathways involving BEX proteins.

Main Results:

  • BEX family proteins play a significant role in regulating cancer cell proliferation and metastasis.
  • They are implicated in diverse biological processes crucial to cancer development, including cell differentiation, proliferation, and apoptosis.
  • BEX proteins influence multiple molecular signaling pathways relevant to various cancers.

Conclusions:

  • BEX family proteins demonstrate potential as therapeutic targets for various cancers.
  • Understanding BEX protein mechanisms can lead to the development of new cancer treatments.
  • Further research into BEX proteins may unlock novel clinical applications in oncology.